QY Research > レポート一覧 > 化学及び材料 > ビスマレイミド (BMI) プリプレグ システムの世界市場レポート2025-2031

ビスマレイミド (BMI) プリプレグ システムの世界市場レポート2025-2031

英文タイトル: Global Bismaleimide (BMI) Prepreg Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

ビスマレイミド (BMI) プリプレグ システムの世界市場レポート2025-2031
  • レポートID:1549179
  • 発表時期:2025-10-03
  • 訪問回数:5
  • ページ数:140
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:148
  • レポートカテゴリ: 化学及び材料

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要


本報告書は、ビスマレイミド (BMI) プリプレグ システムの世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR(年平均成長率)予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別にビスマレイミド (BMI) プリプレグ システム市場を分類しています。

本レポートでは、世界のビスマレイミド (BMI) プリプレグ システム市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートはビスマレイミド (BMI) プリプレグ システムの主要生産者を調査するとともに、主要地域や国の消費状況も提供します。ビスマレイミド (BMI) プリプレグ システムの主要地域/国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです:
Syensqo (Solvay)
Toray
Hexcel
MCCFC
Renegade Materials (Teijin)
GMS Composites
NEXX Technologies (MGCA)

タイプ別市場セグメント:
Autoclave Prepreg
Out-of-Autoclave Prepreg

用途別市場セグメント:
Aerospace and Aviation
Defense
Others

地域別の市場セグメント:
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容:
世界のビスマレイミド (BMI) プリプレグ システム市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてビスマレイミド (BMI) プリプレグ システム市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別(地域レベル、国レベル)のビスマレイミド (BMI) プリプレグ システム生産量、成長率、市場シェアを調査しています。
二. 消費面では、ビスマレイミド (BMI) プリプレグ システムの売上高について、地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーのビスマレイミド (BMI) プリプレグ システム売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界のビスマレイミド (BMI) プリプレグ システム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本ビスマレイミド (BMI) プリプレグ システムレポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次:
第1章: ビスマレイミド (BMI) プリプレグ システムレポートの範囲、市場セグメント(タイプ別、用途別など)ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期(2021-2032年)にわたる発展の見通しを把握いただけます。
第2章: ビスマレイミド (BMI) プリプレグ システムの世界および主要生産者(地域/国別)の生産量/アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています(2021年~2032年)
第3章: ビスマレイミド (BMI) プリプレグ システムの現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します(2021年~2032年)
第4章: ビスマレイミド (BMI) プリプレグ システムメーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します(2021年~2026年)
第5章: ビスマレイミド (BMI) プリプレグ システムの下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章: ビスマレイミド (BMI) プリプレグ システムのグローバル生産能力、稼働率、市場シェア(2021-2032年)をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章: 北米におけるビスマレイミド (BMI) プリプレグ システム市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章: 欧州におけるビスマレイミド (BMI) プリプレグ システム市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章: アジア太平洋地域のビスマレイミド (BMI) プリプレグ システム市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章: 中南米におけるビスマレイミド (BMI) プリプレグ システム市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章:中東・アフリカ地域のビスマレイミド (BMI) プリプレグ システム市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章: ビスマレイミド (BMI) プリプレグ システムの主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章: ビスマレイミド (BMI) プリプレグ システムのサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章: ビスマレイミド (BMI) プリプレグ システムの市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章: レポートの要点と結論
第16章: 付録

biaoTi

Description

The global Bismaleimide (BMI) Prepreg Systems market is projected to grow from US$ 214 million in 2024 to US$ 381 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Bismaleimide (BMI) Prepreg Systems is a composite material used in the aerospace, automotive, and electronics industries for its excellent mechanical and thermal properties. It is a combination of a reinforcing fiber, such as carbon or glass, and a matrix resin called bismaleimide.

The Bismaleimide (BMI) prepreg system market is poised for substantial growth in the coming years, driven by the increasing demand for high-performance materials in various industries, particularly aerospace, automotive, and electronics. As manufacturers seek lightweight yet durable solutions, BMI prepregs offer exceptional thermal stability, chemical resistance, and mechanical properties, making them ideal for applications requiring reliability under extreme conditions. The aerospace sector is a significant contributor to market growth, as BMI prepregs are increasingly utilized in aircraft components, where weight reduction and performance efficiency are critical. Trends indicate a shift towards the development of advanced composite materials that integrate BMI with other resins, enhancing their properties and expanding their applicability across diverse sectors.

One prominent trend is the rising emphasis on sustainability and environmental considerations within the composite materials industry. As manufacturers prioritize eco-friendly practices, the development of bio-based BMI resins is gaining traction, aiming to reduce the carbon footprint associated with traditional manufacturing processes. Furthermore, advancements in manufacturing technologies, such as automated fiber placement and out-of-autoclave curing processes, are enhancing production efficiency and reducing costs, making BMI prepregs more accessible to a wider range of applications. The growing trend of lightweight design in vehicles is also pushing the adoption of BMI prepregs, as automotive manufacturers increasingly focus on improving fuel efficiency and reducing emissions.

However, the BMI prepreg market faces several challenges that could impact its growth trajectory. One of the primary hurdles is the high cost associated with the production of BMI prepregs compared to traditional materials, which can deter some manufacturers from adopting this advanced technology, especially in cost-sensitive industries. Additionally, the curing process for BMI prepregs often requires high temperatures and specialized equipment, leading to increased production complexities and longer lead times. This can be a disadvantage in fast-paced industries where rapid prototyping and production are essential.

Another challenge is the need for improved awareness and understanding of BMI materials among potential users. Despite their advantages, many engineers and designers may still be unfamiliar with the specific benefits and processing techniques of BMI prepregs, leading to hesitation in their adoption. Educating the market on the performance capabilities and applications of BMI materials will be vital for driving acceptance and integration into new projects.

The competitive landscape is also a factor, with several established players and new entrants vying for market share. As the demand for composite materials grows, ongoing innovation and investment in research and development will be crucial for companies looking to differentiate their products and enhance performance features. Collaborations between material suppliers and end-users can facilitate knowledge exchange and drive the development of tailored solutions that meet specific industry needs.

Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Bismaleimide (BMI) Prepreg Systems market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Syensqo (Solvay)
Toray
Hexcel
MCCFC
Renegade Materials (Teijin)
GMS Composites
NEXX Technologies (MGCA)

Segment by Type
Autoclave Prepreg
Out-of-Autoclave Prepreg

Segment by Application
Aerospace and Aviation
Defense
Others

Production by Region
North America
Europe
China
Japan

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina

Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Bismaleimide (BMI) Prepreg Systems study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi

Table of Contents

1 Study Coverage
1.1 Introduction to Bismaleimide (BMI) Prepreg Systems: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bismaleimide (BMI) Prepreg Systems Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Autoclave Prepreg
1.2.3 Out-of-Autoclave Prepreg
1.3 Market Segmentation by Application
1.3.1 Global Bismaleimide (BMI) Prepreg Systems Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Aerospace and Aviation
1.3.3 Defense
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Bismaleimide (BMI) Prepreg Systems Revenue Estimates and Forecasts 2020-2031
2.2 Global Bismaleimide (BMI) Prepreg Systems Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Bismaleimide (BMI) Prepreg Systems Sales Estimates and Forecasts 2020-2031
2.4 Global Bismaleimide (BMI) Prepreg Systems Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis
3.1 Global Bismaleimide (BMI) Prepreg Systems Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan

4 Competition by Manufacturers
4.1 Global Bismaleimide (BMI) Prepreg Systems Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Bismaleimide (BMI) Prepreg Systems Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Autoclave Prepreg Market Size by Manufacturers
4.5.2 Out-of-Autoclave Prepreg Market Size by Manufacturers
4.6 Global Bismaleimide (BMI) Prepreg Systems Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis
5.1 Global Bismaleimide (BMI) Prepreg Systems Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Bismaleimide (BMI) Prepreg Systems Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats

6 Global Downstream Application Analysis
6.1 Global Bismaleimide (BMI) Prepreg Systems Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Bismaleimide (BMI) Prepreg Systems Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application

7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Type (2020-2031)
7.4 North America Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Bismaleimide (BMI) Prepreg Systems Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico

8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Type (2020-2031)
8.4 Europe Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Bismaleimide (BMI) Prepreg Systems Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia

9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Bismaleimide (BMI) Prepreg Systems Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India

10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Type (2020-2031)
10.4 Central and South America Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Bismaleimide (BMI) Prepreg Systems Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Bismaleimide (BMI) Prepreg Systems Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Bismaleimide (BMI) Prepreg Systems Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa

12 Corporate Profile
12.1 Syensqo (Solvay)
12.1.1 Syensqo (Solvay) Corporation Information
12.1.2 Syensqo (Solvay) Business Overview
12.1.3 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.1.4 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems Sales by Product in 2024
12.1.6 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems Sales by Application in 2024
12.1.7 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems Sales by Geographic Area in 2024
12.1.8 Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems SWOT Analysis
12.1.9 Syensqo (Solvay) Recent Developments
12.2 Toray
12.2.1 Toray Corporation Information
12.2.2 Toray Business Overview
12.2.3 Toray Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.2.4 Toray Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Toray Bismaleimide (BMI) Prepreg Systems Sales by Product in 2024
12.2.6 Toray Bismaleimide (BMI) Prepreg Systems Sales by Application in 2024
12.2.7 Toray Bismaleimide (BMI) Prepreg Systems Sales by Geographic Area in 2024
12.2.8 Toray Bismaleimide (BMI) Prepreg Systems SWOT Analysis
12.2.9 Toray Recent Developments
12.3 Hexcel
12.3.1 Hexcel Corporation Information
12.3.2 Hexcel Business Overview
12.3.3 Hexcel Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.3.4 Hexcel Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Hexcel Bismaleimide (BMI) Prepreg Systems Sales by Product in 2024
12.3.6 Hexcel Bismaleimide (BMI) Prepreg Systems Sales by Application in 2024
12.3.7 Hexcel Bismaleimide (BMI) Prepreg Systems Sales by Geographic Area in 2024
12.3.8 Hexcel Bismaleimide (BMI) Prepreg Systems SWOT Analysis
12.3.9 Hexcel Recent Developments
12.4 MCCFC
12.4.1 MCCFC Corporation Information
12.4.2 MCCFC Business Overview
12.4.3 MCCFC Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.4.4 MCCFC Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 MCCFC Bismaleimide (BMI) Prepreg Systems Sales by Product in 2024
12.4.6 MCCFC Bismaleimide (BMI) Prepreg Systems Sales by Application in 2024
12.4.7 MCCFC Bismaleimide (BMI) Prepreg Systems Sales by Geographic Area in 2024
12.4.8 MCCFC Bismaleimide (BMI) Prepreg Systems SWOT Analysis
12.4.9 MCCFC Recent Developments
12.5 Renegade Materials (Teijin)
12.5.1 Renegade Materials (Teijin) Corporation Information
12.5.2 Renegade Materials (Teijin) Business Overview
12.5.3 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.5.4 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems Sales by Product in 2024
12.5.6 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems Sales by Application in 2024
12.5.7 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems Sales by Geographic Area in 2024
12.5.8 Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems SWOT Analysis
12.5.9 Renegade Materials (Teijin) Recent Developments
12.6 GMS Composites
12.6.1 GMS Composites Corporation Information
12.6.2 GMS Composites Business Overview
12.6.3 GMS Composites Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.6.4 GMS Composites Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 GMS Composites Recent Developments
12.7 NEXX Technologies (MGCA)
12.7.1 NEXX Technologies (MGCA) Corporation Information
12.7.2 NEXX Technologies (MGCA) Business Overview
12.7.3 NEXX Technologies (MGCA) Bismaleimide (BMI) Prepreg Systems Product Models, Descriptions and Specifications
12.7.4 NEXX Technologies (MGCA) Bismaleimide (BMI) Prepreg Systems Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 NEXX Technologies (MGCA) Recent Developments

13 Value Chain and Supply-Chain Analysis
13.1 Bismaleimide (BMI) Prepreg Systems Industry Chain
13.2 Bismaleimide (BMI) Prepreg Systems Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Bismaleimide (BMI) Prepreg Systems Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Bismaleimide (BMI) Prepreg Systems Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors

14 Bismaleimide (BMI) Prepreg Systems Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Bismaleimide (BMI) Prepreg Systems Study

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details

biaoTi

Table of Figures

List of Tables
 Table 1. Global Bismaleimide (BMI) Prepreg Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bismaleimide (BMI) Prepreg Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bismaleimide (BMI) Prepreg Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bismaleimide (BMI) Prepreg Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Bismaleimide (BMI) Prepreg Systems Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Bismaleimide (BMI) Prepreg Systems Sales by Region (2020-2025) & (Tons)
 Table 8. Global Bismaleimide (BMI) Prepreg Systems Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Bismaleimide (BMI) Prepreg Systems Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Bismaleimide (BMI) Prepreg Systems Production by Region (2020-2025) & (Tons)
 Table 12. Global Bismaleimide (BMI) Prepreg Systems Production by Region (2026-2031) & (Tons)
 Table 13. Global Bismaleimide (BMI) Prepreg Systems Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Bismaleimide (BMI) Prepreg Systems Sales Share by Manufacturers (2020-2025)
 Table 15. Global Bismaleimide (BMI) Prepreg Systems Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Bismaleimide (BMI) Prepreg Systems Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Bismaleimide (BMI) Prepreg Systems by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bismaleimide (BMI) Prepreg Systems as of 2024)
 Table 19. Global Bismaleimide (BMI) Prepreg Systems Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Bismaleimide (BMI) Prepreg Systems Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
 Table 21. Key Manufacturers Bismaleimide (BMI) Prepreg Systems Manufacturing Base and Headquarters
 Table 22. Global Bismaleimide (BMI) Prepreg Systems Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Bismaleimide (BMI) Prepreg Systems Sales by Type (2020-2025) & (Tons)
 Table 26. Global Bismaleimide (BMI) Prepreg Systems Sales by Type (2026-2031) & (Tons)
 Table 27. Global Bismaleimide (BMI) Prepreg Systems Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Bismaleimide (BMI) Prepreg Systems Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Bismaleimide (BMI) Prepreg Systems ASP by Type (2020-2031) & (US$/Kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Bismaleimide (BMI) Prepreg Systems Sales by Application (2020-2025) & (Tons)
 Table 32. Global Bismaleimide (BMI) Prepreg Systems Sales by Application (2026-2031) & (Tons)
 Table 33. Bismaleimide (BMI) Prepreg Systems High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Bismaleimide (BMI) Prepreg Systems Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Bismaleimide (BMI) Prepreg Systems Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Bismaleimide (BMI) Prepreg Systems ASP by Application (2020-2031) & (US$/Kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Bismaleimide (BMI) Prepreg Systems Growth Accelerators and Market Barriers
 Table 40. North America Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Bismaleimide (BMI) Prepreg Systems Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Bismaleimide (BMI) Prepreg Systems Growth Accelerators and Market Barriers
 Table 43. Europe Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Bismaleimide (BMI) Prepreg Systems Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Bismaleimide (BMI) Prepreg Systems Investment Opportunities and Key Challenges
 Table 50. Central and South America Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Syensqo (Solvay) Corporation Information
 Table 54. Syensqo (Solvay) Description and Major Businesses
 Table 55. Syensqo (Solvay) Product Models, Descriptions and Specifications
 Table 56. Syensqo (Solvay) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 57. Syensqo (Solvay) Sales Value Proportion by Product in 2024
 Table 58. Syensqo (Solvay) Sales Value Proportion by Application in 2024
 Table 59. Syensqo (Solvay) Sales Value Proportion by Geographic Area in 2024
 Table 60. Syensqo (Solvay) Bismaleimide (BMI) Prepreg Systems SWOT Analysis
 Table 61. Syensqo (Solvay) Recent Developments
 Table 62. Toray Corporation Information
 Table 63. Toray Description and Major Businesses
 Table 64. Toray Product Models, Descriptions and Specifications
 Table 65. Toray Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 66. Toray Sales Value Proportion by Product in 2024
 Table 67. Toray Sales Value Proportion by Application in 2024
 Table 68. Toray Sales Value Proportion by Geographic Area in 2024
 Table 69. Toray Bismaleimide (BMI) Prepreg Systems SWOT Analysis
 Table 70. Toray Recent Developments
 Table 71. Hexcel Corporation Information
 Table 72. Hexcel Description and Major Businesses
 Table 73. Hexcel Product Models, Descriptions and Specifications
 Table 74. Hexcel Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 75. Hexcel Sales Value Proportion by Product in 2024
 Table 76. Hexcel Sales Value Proportion by Application in 2024
 Table 77. Hexcel Sales Value Proportion by Geographic Area in 2024
 Table 78. Hexcel Bismaleimide (BMI) Prepreg Systems SWOT Analysis
 Table 79. Hexcel Recent Developments
 Table 80. MCCFC Corporation Information
 Table 81. MCCFC Description and Major Businesses
 Table 82. MCCFC Product Models, Descriptions and Specifications
 Table 83. MCCFC Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 84. MCCFC Sales Value Proportion by Product in 2024
 Table 85. MCCFC Sales Value Proportion by Application in 2024
 Table 86. MCCFC Sales Value Proportion by Geographic Area in 2024
 Table 87. MCCFC Bismaleimide (BMI) Prepreg Systems SWOT Analysis
 Table 88. MCCFC Recent Developments
 Table 89. Renegade Materials (Teijin) Corporation Information
 Table 90. Renegade Materials (Teijin) Description and Major Businesses
 Table 91. Renegade Materials (Teijin) Product Models, Descriptions and Specifications
 Table 92. Renegade Materials (Teijin) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Renegade Materials (Teijin) Sales Value Proportion by Product in 2024
 Table 94. Renegade Materials (Teijin) Sales Value Proportion by Application in 2024
 Table 95. Renegade Materials (Teijin) Sales Value Proportion by Geographic Area in 2024
 Table 96. Renegade Materials (Teijin) Bismaleimide (BMI) Prepreg Systems SWOT Analysis
 Table 97. Renegade Materials (Teijin) Recent Developments
 Table 98. GMS Composites Corporation Information
 Table 99. GMS Composites Description and Major Businesses
 Table 100. GMS Composites Product Models, Descriptions and Specifications
 Table 101. GMS Composites Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 102. GMS Composites Recent Developments
 Table 103. NEXX Technologies (MGCA) Corporation Information
 Table 104. NEXX Technologies (MGCA) Description and Major Businesses
 Table 105. NEXX Technologies (MGCA) Product Models, Descriptions and Specifications
 Table 106. NEXX Technologies (MGCA) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 107. NEXX Technologies (MGCA) Recent Developments
 Table 108. Key Raw Materials Distribution
 Table 109. Raw Materials Key Suppliers
 Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 111. Milestones in Production Technology Evolution
 Table 112. Distributors List
 Table 113. Market Trends and Market Evolution
 Table 114. Market Drivers and Opportunities
 Table 115. Market Challenges, Risks, and Restraints
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bismaleimide (BMI) Prepreg Systems Product Picture
 Figure 2. Global Bismaleimide (BMI) Prepreg Systems Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Autoclave Prepreg Product Picture
 Figure 4. Out-of-Autoclave Prepreg Product Picture
 Figure 5. Global Bismaleimide (BMI) Prepreg Systems Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Aerospace and Aviation
 Figure 7. Defense
 Figure 8. Others
 Figure 9. Bismaleimide (BMI) Prepreg Systems Report Years Considered
 Figure 10. Global Bismaleimide (BMI) Prepreg Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Bismaleimide (BMI) Prepreg Systems Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Bismaleimide (BMI) Prepreg Systems Revenue Market Share by Region (2020-2031)
 Figure 14. Global Bismaleimide (BMI) Prepreg Systems Sales (2020-2031) & (Tons)
 Figure 15. Global Bismaleimide (BMI) Prepreg Systems Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Bismaleimide (BMI) Prepreg Systems Sales Market Share by Region (2020-2031)
 Figure 17. Global Bismaleimide (BMI) Prepreg Systems Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Bismaleimide (BMI) Prepreg Systems Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Bismaleimide (BMI) Prepreg Systems Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Bismaleimide (BMI) Prepreg Systems Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Bismaleimide (BMI) Prepreg Systems Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Bismaleimide (BMI) Prepreg Systems Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Bismaleimide (BMI) Prepreg Systems Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Volume Market Share in 2024
 Figure 26. Global Bismaleimide (BMI) Prepreg Systems Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Autoclave Prepreg Revenue Market Share by Manufacturer in 2024
 Figure 29. Out-of-Autoclave Prepreg Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Bismaleimide (BMI) Prepreg Systems Sales Market Share by Type (2020-2031)
 Figure 33. Global Bismaleimide (BMI) Prepreg Systems Revenue Market Share by Type (2020-2031)
 Figure 34. Global Bismaleimide (BMI) Prepreg Systems Sales Market Share by Application (2020-2031)
 Figure 35. Global Bismaleimide (BMI) Prepreg Systems Revenue Market Share by Application (2020-2031)
 Figure 36. North America Bismaleimide (BMI) Prepreg Systems Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Bismaleimide (BMI) Prepreg Systems Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) in 2024
 Figure 39. North America Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Bismaleimide (BMI) Prepreg Systems Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Bismaleimide (BMI) Prepreg Systems Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 54. France Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 69. India Bismaleimide (BMI) Prepreg Systems Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Bismaleimide (BMI) Prepreg Systems Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Bismaleimide (BMI) Prepreg Systems Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Bismaleimide (BMI) Prepreg Systems Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Bismaleimide (BMI) Prepreg Systems Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Bismaleimide (BMI) Prepreg Systems Revenue (2020-2025) & (US$ Million)
 Figure 90. Bismaleimide (BMI) Prepreg Systems Industry Chain Mapping
 Figure 91. Regional Bismaleimide (BMI) Prepreg Systems Manufacturing Base Distribution (%)
 Figure 92. Bismaleimide (BMI) Prepreg Systems Production Process
 Figure 93. Regional Bismaleimide (BMI) Prepreg Systems Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)